News & Publications

CAMBRIDGE, Mass. and LOS ANGELES, Dec. 19, 2022 -- RadNet, Inc., today announced that its subsidiary DeepHealth, Inc., a leading developer

At the 2022 annual meeting of the Radiology Society of North America (RSNA), members of Dr. Sorensen’s DeepHealth team have

RadNet, Inc. announced that it has received FDA clearances for its DeepHealth Saige-Dx™ mammography and Quantib® Prostate 2.0 MRI artificial intelligence (“AI”) algorithms. Saige-DX:

DeepHealth is eager to demonstrate its new FDA-cleared AI product, Saige-Dx, at the SBI-ACR Breast Imaging Symposium 2022, as well as other technologies

Facing the Future with Confidence: How the Latest AI Tool Enhances Radiologist Performance The next-generation AI tool is ready. Drs. Holt, Sorenson, and

RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with

What makes DeepHealth’s Artificial Intelligence tools for mammography different? RSNA attendees have many opportunities to discover how DeepHealth is transforming imaging. Sunday,

RadNet announces that DeepHealth, a leading developer of artificial intelligence (AI) for mammography interpretation, has received FDA clearance for its mammography triage software Saige-Q.

From April 9-11, 2021, DeepHealth will participate in the Society of Breast Imaging virtual symposium.

MIT’s Research collaboration lab highlights DeepHealth in a company spotlight article, shown on MIT's CSAIL (Computer Science and Artificial Intelligence) Alliances website.

DeepHealth published results of its novel algorithms in Nature Medicine.

DeepHealth is participating in RSNA 2020, a virtual conference. Attendees can schedule one-on-one sessions with experts in artificial intelligence.